Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07300956 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treating Young Children With Attention Deficit Hyperactivity Disorder

Study acronym: TYCA
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Feb 2026 to Feb 16, 2026 · Site details revised at 5 of 5 sitesv3 Show 2 more changesShow less
    • Start date changed from estimate of Feb 2026 to Feb 16, 2026
    • Site details revised at 5 of 5 sites
  2. Primary endpoint revised Secondary endpoints: details revised at 7 of 7 entriesv2 Show 1 more changeShow less
    • Secondary endpoints: details revised at 7 of 7 entries

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project will evaluate the effectiveness of Methylphenidate versus Guanfacine in treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 3 through 5 years (inclusive), as measured by clinician rating of global improvement.
Trial Details
NCT Number NCT07300956
Lead Sponsor Children's Hospital Medical Center, Cincinnati
Collaborators: Patient-Centered Outcomes Research Institute, Children's Hospital of Philadelphia, Developmental Behavioral Pediatrics Research Network, Boston Children's Hospital, Boston, MA, USA, Children's Mercy Hospital Kansas City, Stanford University
Conditions Attention-Deficit/Hyperactivity Disorder (ADHD)
Enrollment 370 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov